bentonite-based nanomedicine (Lorati)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Namebentonite-based nanomedicine (Lorati)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTransmembrane glycoprotein gp41 modulatorsHIV envelope protein gp120 modulators
TargetsHIV envelope protein gp120Transmembrane glycoprotein gp41
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLorati Company Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLorati Company Ltd
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A